Skip to main content
Advertisement
Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis

June 2, 2026

Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis

Using data from >90,000 singleton pregnancies, Kelly Hughes and colleagues quantify the prognostic value of mid-trimester cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy, and assess other factors which may modify this association.

Image credit: Kari Alfonso, Pexels

Recently Published Articles

Current Issue

Browse Issues 2004 – 2026

06/01/2026

Perspective

The NIH 2025 Public Access Policy: Immediate access, unequal costs

In this Perspective, Caitlin Ryus and colleagues discuss the NIH 2025 Public Access Policy, highlighting that while expanding who can read science, the policy risks creating new barriers to who can afford to perform and publish their science.

Image credit: Mathieu Stern, Unsplash

The NIH 2025 Public Access Policy: Immediate access, unequal costs

05/29/2026

Perspective

Availability, appeal, and addictiveness by design: Tobacco and nicotine industry deliberate targeting of youth

In recognition of the World No Tobacco Day 2026 theme, "unmasking the appeal", Emily Banks and colleagues discuss how tobacco and nicotine products, particularly e-cigarettes, are designed and marketed to maximize youth appeal, and highlight the need for policies to ensure greater industry accountability and to tackle concerning uptake trends.

Availability, appeal, and addictiveness by design: Tobacco and nicotine industry deliberate targeting of youth

Image credit: Paul Bill, Unsplash

05/27/2026

Research Article

Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial

In a randomized open-label trial, Wei-Xiang Qi and colleagues investigate the feasibility of dose-reduced thoracic radiotherapy to mitigate treatment related toxicities while preserving oncological outcomes in older patients with Stage III Non-small-cell Lung Cancer.

Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial

Image credit: Craig Cameron, Unsplash

Get new content from PLOS Medicine in your inbox

PLOS Medicine | ISSN: 1549-1676 (online)